Literature DB >> 24694308

USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy.

Jessica A Hall1, Mitsuhisa Tabata, Joseph T Rodgers, Pere Puigserver.   

Abstract

Hepatic forkhead protein FoxO1 is a key component of systemic glucose homeostasis via its ability to regulate the transcription of rate-limiting enzymes in gluconeogenesis. Important in the regulation of FoxO1 transcriptional activity are the modifying/demodifying enzymes that lead to posttranslational modification. Here, we demonstrate the functional interaction and regulation of FoxO1 by herpesvirus-associated ubiquitin-specific protease 7 (USP7; also known as herpesvirus-associated ubiquitin-specific protease, HAUSP), a deubiquitinating enzyme. We show that USP7-mediated mono-deubiquitination of FoxO1 results in suppression of FoxO1 transcriptional activity through decreased FoxO1 occupancy on the promoters of gluconeogenic genes. Knockdown of USP7 in primary hepatocytes leads to increased expression of FoxO1-target gluconeogenic genes and elevated glucose production. Consistent with this, USP7 gain-of-function suppresses the fasting/cAMP-induced activation of gluconeogenic genes in hepatocyte cells and in mouse liver, resulting in decreased hepatic glucose production. Notably, we show that the effects of USP7 on hepatic glucose metabolism depend on FoxO1. Together, these results place FoxO1 under the intimate regulation of deubiquitination and glucose metabolic control with important implication in diseases such as diabetes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24694308      PMCID: PMC4042075          DOI: 10.1210/me.2013-1420

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  65 in total

1.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.

Authors:  Muyang Li; Delin Chen; Ariel Shiloh; Jianyuan Luo; Anatoly Y Nikolaev; Jun Qin; Wei Gu
Journal:  Nature       Date:  2002-03-31       Impact factor: 49.962

Review 2.  Unravelling the tumor-suppressive functions of FOXO proteins.

Authors:  Tobias B Dansen; Boudewijn M T Burgering
Journal:  Trends Cell Biol       Date:  2008-08-18       Impact factor: 20.808

3.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1.

Authors:  S Herzig; F Long; U S Jhala; S Hedrick; R Quinn; A Bauer; D Rudolph; G Schutz; C Yoon; P Puigserver; B Spiegelman; M Montminy
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

4.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.

Authors:  J C Yoon; P Puigserver; G Chen; J Donovan; Z Wu; J Rhee; G Adelmant; J Stafford; C R Kahn; D K Granner; C B Newgard; B M Spiegelman
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

5.  The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression.

Authors:  J Nakae; T Kitamura; D L Silver; D Accili
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

6.  DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells.

Authors:  N Nasrin; S Ogg; C M Cahill; W Biggs; S Nui; J Dore; D Calvo; Y Shi; G Ruvkun; M C Alexander-Bridges
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

7.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding.

Authors:  Xiaohui Zhang; Lixia Gan; Haiyun Pan; Shaodong Guo; Xiaowei He; Steven T Olson; Andrew Mesecar; Stephen Adam; Terry G Unterman
Journal:  J Biol Chem       Date:  2002-09-12       Impact factor: 5.157

9.  Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.

Authors:  Jennifer Altomonte; Anja Richter; Sonal Harbaran; Jenny Suriawinata; Jun Nakae; Swan N Thung; Marcia Meseck; Domenico Accili; Hengjiang Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-06-03       Impact factor: 4.310

10.  Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.

Authors:  Pere Puigserver; James Rhee; Jerry Donovan; Christopher J Walkey; J Cliff Yoon; Francesco Oriente; Yukari Kitamura; Jennifer Altomonte; Hengjiang Dong; Domenico Accili; Bruce M Spiegelman
Journal:  Nature       Date:  2003-05-18       Impact factor: 49.962

View more
  17 in total

1.  Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.

Authors:  Julia E Rager; Sloane K Tilley; Samantha E Tulenko; Lisa Smeester; Paul D Ray; Andrew Yosim; Jenna M Currier; María C Ishida; Maria Del Carmen González-Horta; Blanca Sánchez-Ramírez; Lourdes Ballinas-Casarrubias; Daniela S Gutiérrez-Torres; Zuzana Drobná; Luz M Del Razo; Gonzalo G García-Vargas; William Y Kim; Yi-Hui Zhou; Fred A Wright; Miroslav Stýblo; Rebecca C Fry
Journal:  Chem Res Toxicol       Date:  2015-06-03       Impact factor: 3.739

2.  Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.

Authors:  Gerald Gavory; Colin R O'Dowd; Matthew D Helm; Jakub Flasz; Elias Arkoudis; Anthony Dossang; Caroline Hughes; Eamon Cassidy; Keeva McClelland; Ewa Odrzywol; Natalie Page; Oliver Barker; Hugues Miel; Timothy Harrison
Journal:  Nat Chem Biol       Date:  2017-12-04       Impact factor: 15.040

3.  Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis.

Authors:  Lu Jiang; Jiannan Xiong; Junsi Zhan; Fengjie Yuan; Ming Tang; Chaohua Zhang; Ziyang Cao; Yongcan Chen; Xiaopeng Lu; Yinglu Li; Hui Wang; Lina Wang; Jiadong Wang; Wei-Guo Zhu; Haiying Wang
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

4.  RNA-seq analysis provides insight into molecular adaptations of Andrias davidianus.

Authors:  Xiaofang Geng; Lu Zhang; Xiayan Zang; Jianlin Guo; Cunshuan Xu
Journal:  Dev Genes Evol       Date:  2019-11-16       Impact factor: 0.900

Review 5.  Ubiquitin-related processes and innate immunity in C. elegans.

Authors:  Juan A Garcia-Sanchez; Jonathan J Ewbank; Orane Visvikis
Journal:  Cell Mol Life Sci       Date:  2021-02-25       Impact factor: 9.261

Review 6.  Insulin regulation of gluconeogenesis.

Authors:  Maximilian Hatting; Clint D J Tavares; Kfir Sharabi; Amy K Rines; Pere Puigserver
Journal:  Ann N Y Acad Sci       Date:  2017-09-03       Impact factor: 5.691

7.  The Deubiquitylase MATH-33 Controls DAF-16 Stability and Function in Metabolism and Longevity.

Authors:  Thomas Heimbucher; Zheng Liu; Carine Bossard; Richard McCloskey; Andrea C Carrano; Christian G Riedel; Bogdan Tanasa; Christian Klammt; Bryan R Fonslow; Celine E Riera; Bjorn F Lillemeier; Kenneth Kemphues; John R Yates; Clodagh O'Shea; Tony Hunter; Andrew Dillin
Journal:  Cell Metab       Date:  2015-07-07       Impact factor: 27.287

8.  The C. elegans Ortholog of USP7 controls DAF-16 stability in Insulin/IGF-1-like signaling.

Authors:  Thomas Heimbucher; Tony Hunter
Journal:  Worm       Date:  2015-11-17

Review 9.  Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.

Authors:  Amy K Rines; Kfir Sharabi; Clint D J Tavares; Pere Puigserver
Journal:  Nat Rev Drug Discov       Date:  2016-08-12       Impact factor: 84.694

Review 10.  Forkhead Box Protein O1: Functional Diversity and Post-Translational Modification, a New Therapeutic Target?

Authors:  Xiaojun Zhang; Lusheng Jiang; Huimin Liu
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.